HER3: The Comeback Kid in Cancer Research

Turns out HER3, once thought to be a benchwarmer in cancer, is actually a major player! Scientists now say HER3 helps tumors survive and resist treatment, especially in breast and lung cancers. The catch? Not all patients benefit from HER3-targeted drugs—only those with active HER3 signaling. New antibody-drug combos are showing promise, but matching the right patients is key. HER3 might finally get its moment as a precision cancer therapy superstar! #CancerResearch #HER3 #PrecisionMedicine #Oncology #MedicalBreakthrough #Health